Juvise Pharmaceuticals Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
115
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
8
- Investments
-
2
Juvise Pharmaceuticals General Information
Description
Manufacturer of pharmaceutical products across various therapeutic areas. The company focuses on acquiring, developing and commercialising as well as offers products related to oncology, gastroenterology, cardiology, rheumatology and neuropsychiatric, thereby providing clients access to a diverse portfolio of specialised medications to meet the needs of patients with various medical conditions.
Contact Information
Website
www.juvisepharmaceuticals.comCorporate Office
- 28, rue Bayard
- 75008 Paris
- France
Corporate Office
- 28, rue Bayard
- 75008 Paris
- France
Juvise Pharmaceuticals Timeline
Juvise Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Juvise Pharmaceuticals Patents
Juvise Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4415699-A1 | Methods of treating multiple sclerosis | Inactive | 11-Oct-2021 | ||
| EP-4415712-A1 | Methods of treating multiple sclerosis | Inactive | 11-Oct-2021 | ||
| AU-2022236428-A1 | Pharmaceutical dosage system | Pending | 17-Mar-2021 | ||
| EP-4308061-A1 | Pharmaceutical dosage system | Pending | 17-Mar-2021 | ||
| AU-2018233109-A1 | Pharmaceutical combination comprising ponesimod | Active | 14-Mar-2017 | A61K31/277 |
Juvise Pharmaceuticals Signals
Juvise Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Juvise Pharmaceuticals Investments (2)
Juvise Pharmaceuticals’s most recent deal was a Buyout/LBO with Actelion Pharmaceuticals (Global Trade Rights to Ponvory). The deal was made on 26-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Actelion Pharmaceuticals (Global Trade Rights to Ponvory) | 26-Mar-2024 | Buyout/LBO | Buildings and Property | ||
| AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) | 20-Dec-2019 | Corporate Asset Purchase | Buildings and Property |
Juvise Pharmaceuticals FAQs
-
When was Juvise Pharmaceuticals founded?
Juvise Pharmaceuticals was founded in 2008.
-
Where is Juvise Pharmaceuticals headquartered?
Juvise Pharmaceuticals is headquartered in Paris, France.
-
What is the size of Juvise Pharmaceuticals?
Juvise Pharmaceuticals has 115 total employees.
-
What industry is Juvise Pharmaceuticals in?
Juvise Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Juvise Pharmaceuticals a private or public company?
Juvise Pharmaceuticals is a Private company.
-
What is Juvise Pharmaceuticals’s current revenue?
The current revenue for Juvise Pharmaceuticals is .
-
How much funding has Juvise Pharmaceuticals raised over time?
Juvise Pharmaceuticals has raised $886M.
-
Who are Juvise Pharmaceuticals’s investors?
Bpifrance, Pemberton Asset Management, and CIC Private Debt have invested in Juvise Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process